<VariationArchive VariationID="369923" VariationName="NM_023067.4(FOXL2):c.663_692dup (p.Ala225_Ala234dup)" VariationType="Duplication" Accession="VCV000369923" Version="5" RecordType="classified" NumberOfSubmissions="4" NumberOfSubmitters="4" DateLastUpdated="2024-05-08" DateCreated="2016-12-18" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="354118" VariationID="369923">
      <GeneList>
        <Gene Symbol="FOXL2" FullName="forkhead box L2" GeneID="668" HGNC_ID="HGNC:1092" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>3q22.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="138944224" stop="138947137" display_start="138944224" display_stop="138947137" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="138663065" stop="138665981" display_start="138663065" display_stop="138665981" Strand="-" />
          </Location>
          <OMIM>605597</OMIM>
          <Haploinsufficiency last_evaluated="2021-02-09" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FOXL2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-02-09" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FOXL2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_023067.4(FOXL2):c.663_692dup (p.Ala225_Ala234dup)</Name>
      <CanonicalSPDI>NC_000003.12:138946030:GCCGCAGCTGCTGCAGCCGCTGCGGCTGCCGCC:GCCGCAGCTGCTGCAGCCGCTGCGGCTGCCGCCGCAGCTGCTGCAGCCGCTGCGGCTGCCGCC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>3q22.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="138946030" stop="138946031" display_start="138946030" display_stop="138946031" variantLength="30" positionVCF="138946030" referenceAlleleVCF="A" alternateAlleleVCF="AGCCGCAGCTGCTGCAGCCGCTGCGGCTGCC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="138664872" stop="138664873" display_start="138664872" display_stop="138664873" variantLength="30" positionVCF="138664872" referenceAlleleVCF="A" alternateAlleleVCF="AGCCGCAGCTGCTGCAGCCGCTGCGGCTGCC" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.138664876_138664905dup" Assembly="GRCh37">
            <Expression>NC_000003.11:g.138664876_138664905dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.138946034_138946063dup" Assembly="GRCh38">
            <Expression>NC_000003.12:g.138946034_138946063dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012454.1" sequenceAccession="NG_012454" sequenceVersion="1" change="g.6081_6110dup">
            <Expression>NG_012454.1:g.6081_6110dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_029796.1" sequenceAccession="NG_029796" sequenceVersion="1" change="g.3801_3830dup">
            <Expression>NG_029796.1:g.3801_3830dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_023067.4" sequenceAccession="NM_023067" sequenceVersion="4" change="c.663_692dup" MANESelect="true">
            <Expression>NM_023067.4:c.663_692dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_075555.1" sequenceAccession="NP_075555" sequenceVersion="1" change="p.Ala225_Ala234dup">
            <Expression>NP_075555.1:p.Ala225_Ala234dup</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001821" Type="inframe_insertion" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1295" sequenceAccession="LRG_1295">
            <Expression>LRG_1295:g.6081_6110dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1295t1" sequenceAccession="LRG_1295t1">
            <Expression>LRG_1295t1:c.663_692dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1295p1" sequenceAccession="LRG_1295p1" change="p.Ala225_Ala234dup">
            <Expression>LRG_1295p1:p.Ala225_Ala234dup</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA10654871" DB="ClinGen" />
        <XRef Type="rs" ID="764243782" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_023067.4(FOXL2):c.663_692dup (p.Ala225_Ala234dup) AND Blepharophimosis, ptosis, and epicanthus inversus syndrome" Accession="RCV000408883" Version="3">
        <ClassifiedConditionList TraitSetID="1337">
          <ClassifiedCondition DB="MedGen" ID="C0220663">Blepharophimosis, ptosis, and epicanthus inversus syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2017-01-01" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_023067.4(FOXL2):c.663_692dup (p.Ala225_Ala234dup) AND not provided" Accession="RCV002524615" Version="3">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-07-19" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-07-19" NumberOfSubmissions="4" NumberOfSubmitters="4" DateCreated="2016-12-18" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">18642388</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23441113</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1337" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4679" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Blepharophimosis, ptosis, and epicanthus inversus</ElementValue>
                <XRef ID="Blepharophimosis%2C+ptosis%2C+and+epicanthus+inversus/7828" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Blepharophimosis, ptosis, and epicanthus inversus syndrome</ElementValue>
                <XRef ID="3351" DB="GeneTests" />
                <XRef ID="MONDO:0007201" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">BPES</ElementValue>
                <XRef Type="MIM" ID="110100" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Blepharophimosis, ptosis, and epicanthus inversus syndrome (BPES) is defined by a complex eyelid malformation characterized by four major features, all present at birth: blepharophimosis, ptosis, epicanthus inversus, and telecanthus. BPES type I includes the four major features and primary ovarian insufficiency; BPES type II includes only the four major features. Other ophthalmic manifestations that can be associated with BPES include dysplastic eyelids, lacrimal duct anomalies, strabismus, refractive errors, and amblyopia. Other craniofacial features may include a broad nasal bridge and low-set ears.</Attribute>
                <XRef ID="NBK1441" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="23" />
                <XRef ID="23" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301614</ID>
                <ID Source="BookShelf">NBK1441</ID>
              </Citation>
              <XRef ID="126" DB="Orphanet" />
              <XRef ID="C0220663" DB="MedGen" />
              <XRef ID="MONDO:0007201" DB="MONDO" />
              <XRef Type="MIM" ID="110100" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="948356" SubmissionDate="2016-12-14" DateLastUpdated="2016-12-18" DateCreated="2016-12-18">
        <ClinVarSubmissionID localKey="FOXL2-41|OMIM:110100" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000484883" DateUpdated="2016-12-18" DateCreated="2016-12-18" Type="SCV" Version="1" SubmitterName="Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia" OrgID="165021" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-11-03">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">DGD Variant Analysis Guidelines</Attribute>
          <Citation Type="general">
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/q5qzurm4/dgd_variant_analysis_guidelines.docx</URL>
            <CitationText>DGD_Variant_Analysis_Guidelines.docx</CitationText>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="12" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="VariantChromosomes" integerValue="12" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FOXL2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>p.[Ala225_Ala234dup]</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_023067.3:c.663_692dup30</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="110100" Type="MIM" />
          </Trait>
        </TraitSet>
        <StudyDescription>Clinical Testing</StudyDescription>
        <Comment>Clinical Testing</Comment>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1807765" SubmissionDate="2019-03-08" DateLastUpdated="2019-06-23" DateCreated="2019-06-23">
        <ClinVarSubmissionID localKey="c.663_692dup" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000924429" DateUpdated="2019-06-23" DateCreated="2019-06-23" Type="SCV" Version="1" SubmitterName="Wessex Regional Genetics Laboratory, Salisbury District Hospital" OrgID="506925" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-01-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>de novo</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <TypePlatform>Sanger sequencing</TypePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
          <ObservedIn>
            <Sample>
              <Origin>de novo</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <TypePlatform>Sanger sequencing</TypePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FOXL2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>p.(Ala225_Ala234dup)</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_023067.3:c.663_692dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="110100" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5295063</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7331079" SubmissionDate="2023-05-03" DateLastUpdated="2023-05-06" DateCreated="2023-05-06">
        <ClinVarSubmissionID localKey="GDXSV:269879" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV003921710" DateUpdated="2023-05-06" DateCreated="2023-05-06" Type="SCV" Version="1" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-04-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Predicted to result in an in-frame addition of 10 amino acids in a poly-alanine tract; Not observed in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 23441113, 31048069, 27283035)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FOXL2" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:3999656</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_023067.3:c.663_692dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_182_20230503054203</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5996685" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="15841777|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003313949" DateUpdated="2024-02-20" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-07-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">18642388</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23441113</ID>
          </Citation>
          <Comment>This variant is not present in population databases (gnomAD no frequency). This variant, c.663_692dup, results in the insertion of 10 amino acid(s) of the FOXL2 protein (p.Ala225_Ala234dup), but otherwise preserves the integrity of the reading frame. This variant has been observed in individuals with FOXL2-related conditions (PMID: 18642388, 23441113). It has also been observed to segregate with disease in related individuals. For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 369923).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FOXL2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000003.11:g.138664872_138664873insGCCGCAGCTGCTGCAGCCGCTGCGGCTGCC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200279</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="948356" TraitType="Disease" MappingType="XRef" MappingValue="110100" MappingRef="OMIM">
        <MedGen CUI="C0220663" Name="Blepharophimosis, ptosis, and epicanthus inversus syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5996685" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1807765" TraitType="Disease" MappingType="XRef" MappingValue="110100" MappingRef="OMIM">
        <MedGen CUI="C0220663" Name="Blepharophimosis, ptosis, and epicanthus inversus syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7331079" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

